On September 16, the domestic leader in laser diagnosis and treatment technology innovation, Microlight Medical, announced that it had completed a D1 round of financing worth more than 100 million yuan. This round of financing was led by Huajin Capital and Rehabilitation Capital, followed by Kaihe Capital and its old shareholders, Sequoia China and Zhongke Chuangxing. It is understood that this round of financing will be used for the development and clinical application of laser therapy products in the brain, peripheral and ophthalmology fields.
Founded in 2012, Shenzhen Zhongke Low Light Medical Device Technology Co., Ltd. is a pioneer and innovation leader in the field of laser medicine in China. Since its founding 10 years ago, it has always adhered to the development and independent innovation of the underlying core technology, and created three underlying core technology platforms, namely, ultrafast laser, optical fiber conduit and image processing. At present, it has more than 140 independent intellectual property rights. A number of LLL products have created the first in the industry: developed and produced China's first export cardiovascular OCT imaging system, the world's first mobile cardiovascular OCT imaging system, the world's first multimodal OCT imaging system, established the world's first fully automatic OCT optical fiber probe production line, and created China's first and the world's second infrared vascular imager segmentation brand.
According to the data of FortuneBusiness, an American research institution, the global market size of medical laser equipment will be about 4.15 billion dollars in 2021, and the annual compound growth rate is expected to be 16.8% in the next eight years; According to the prediction of Frost Sullivan, a consulting company, the market size of China's medical laser will exceed 30 billion yuan in 2022. The market has huge development space and has become a new track that cannot be ignored. At present, the application of laser in the medical field is increasingly popular. From ophthalmology and surgery to cardiovascular, internal medicine, gynecology, otorhinolaryngology, dermatology, etc., all have become the applicable fields of laser medical devices.
The P80 cardiovascular OCT system newly released by LLL Medical is an OCT intracavitary imaging system with more advanced technology and higher technology. Compared with imported products, it has 13 unique and leading indicators. At the same time, Microlight is also the domestic brand with the most complete OCT product pipeline in the industry. In other diagnosis and treatment fields such as pan vascular, urology and ophthalmology, such as carotid artery OCT and cold laser ablation, new progress has also been made and will be put into clinical use as soon as possible. In addition, LLL Medical is also making every effort to promote the localization of core devices, so as to ensure the safety of the supply chain while reducing costs.
Since 2021, the sales volume of LLL OCT products has grown rapidly and has occupied the leading share of domestic OCT products. In many subdivided fields of laser medicine, monopoly giants have not yet emerged in the market. As a leading laser medical enterprise in China, Microlight Medical will promote the technological innovation of laser in multiple clinical directions based on its accumulated technology and product advantages.
Source: Cloud Hunting Network
